Fabian Deutskens
Global Director Vaccine Research and Discovery @CEVA SANTE ANIMALE
Signup · Get unlimited contacts
WORK HISTORY
Global Director Vaccine Research and Discovery @CEVA SANTE ANIMALE
Lead global Discovery organization of 50+ scientists across Japan, Germany, France, U.S, and Canada, driving next-generation vaccine innovation.Integrate genomics, bioinformatics, and AI to accelerate antigen discovery across RNA, DNA, viral vector, and recombinant protein vaccine platforms.Establish scientific ecosystems connecting data, people, and purpose to deliver actionable vaccine candidates impacting global animal health.Implement pipeline governance, aligning R&D projects with strategic business objectives.Foster cross-cultural, high-performing teams, increasing productivity and innovation
EDUCATION
Justus Liebig University Giessen
Dr. med. vet. (summa cum laude)
Justus Liebig University Giessen
Staatsexamen, Veterinary Medicine
SKILLS
ABOUT FABIAN DEUTSKENS
I’m a results-driven R&D leader with over a decade of experience turning complex scientific ideas into impactful animal health solutions. Combining deep veterinary and scientific expertise with strong business acumen, I’ve led cross-functional, international teams in the pre-clinical, clinical, and industrialization stages of vaccine development.My strength lies in connecting science with strategy — aligning innovation with business goals to deliver products that improve animal welfare and commercial outcomes. Known for my analytical mindset, problem-solving capability, and collaborative leadership style, I foster high-performing, purpose-driven teams that thrive across disciplines and cultures.I’m passionate about advancing the next generation of vaccines that redefine standards in animal health — where science, strategy, and impact meet.Key Highlights:Advanced 10+ vaccine candidates from discovery to pre-clinical validation.Directed global teams spanning Japan, Germany, France, the U.S, and Canada.Built state-of-the-art laboratories for early-stage vaccine development.Ensured regulatory compliance and served as biosafety authorization holder under §44 IfSG, §2 TierSeuchErV, §15 GenTSV.Awarded summa cum laude and Best PhD Thesis for contributions to vaccine safety research.Skills:Vaccine R&D | Pre-clinical & Clinical Development | Portfolio ManagementViral, Bacterial, RNA, DNA, Recombinant Platforms | Genomics | Bioinformatics | AI in DiscoveryCross-functional Leadership | Global Team Management | Innovation EcosystemsRegulatory Compliance | GLP/GMP | Biosafety OversightTechnology Scouting | Open Innovation | Strategic Planning
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.